Up-regulation of CXCL8 Expression is Associated with a Poor Prognosis and Enhances Tumor Cell Malignant Behaviors in Liver Cancer

Overview

Journal Biosci Rep

Specialty Cell Biology

Date 2020 Aug 9

PMID 32766720

Citations 10

Authors

Song Yang

Han Wang

Chundi Qin

Hongmei Sun

Yupeng Han

Affiliations

Soon will be listed here.

Abstract

CXCL8, a member of CXC chemokines, was constitutively expressed in many types of human cancers, and its overexpression has been shown to play a critical role in promoting tumorigenesis. The purpose of the present study was to determine CXCL8 expression in a commercial human liver tissue microarray, and elucidate the effects and underlying mechanisms by which CXCL8 is involved in the malignant progression of human liver cancer. Our data showed that high level expression of CXCL8 in tissues with liver cancer was identified as compared with non-cancer tissues, and its up-regulation was closely associated with clinical stage and tumor infiltration. In vitro, exogenous CXCL8 at concentrations of 10, 20 or 40 ng/ml obviously stimulated the proliferation abilities of HepG2 cells. Coupled with this, 10, 20 or 40 ng/ml of exogenous CXCL8 also triggered a significant elevation in HepG2 cells migration. Additionally, overexpression of CXCL8 in HepG2 cells also resulted in increased cell proliferation and migration capacities. Finally, Western blotting analysis showed that overexpression of CXCL8 increased the expression of ERK, p-ERK and survivin, decreased the expression of caspase-3 and BAX at protein level.

Citing Articles

DDX17-Mediated Upregulation of CXCL8 Promotes Hepatocellular Carcinoma Progression Co-activating β-catenin/NF-κB Complex.

Liu H, Gao X, Zhang W, Fu X, Zhang J, Yuan Q Int J Biol Sci. 2025; 21(3):1342-1360.

PMID: 39897048 PMC: 11781183. DOI: 10.7150/ijbs.104165.

Prognostic values of intracellular cell-related genes in esophageal cancer and their regulatory mechanisms.

Cao W, Jin D, Min W, Li H, Wang R, Zhang J BMC Cancer. 2025; 25(1):105.

PMID: 39833728 PMC: 11744837. DOI: 10.1186/s12885-025-13483-8.

Expression of CXCL8 and its relationship with prognosis in patients with non-small cell lung cancer.

Ma X, Zhu X, Zou M, Zhang J, Huang L, Jiang S Am J Cancer Res. 2024; 14(6):2934-2945.

PMID: 39005665 PMC: 11236764. DOI: 10.62347/LJDQ3897.

Therapeutic Peptide RF16 Derived from CXCL8 Inhibits MDA-MB-231 Cell Invasion and Metastasis.

Chang C, Chang C, Lam H, Peng S, Lai Y, Hsiang B Int J Mol Sci. 2023; 24(18).

PMID: 37762330 PMC: 10531501. DOI: 10.3390/ijms241814029.

Novel insights into the progression and prognosis of the calpain family members in hepatocellular carcinoma: a comprehensive integrated analysis.

Dai D, Wu D, Ni R, Li P, Tian Z, Shui Y Front Mol Biosci. 2023; 10:1162409.

PMID: 37503539 PMC: 10368982. DOI: 10.3389/fmolb.2023.1162409.

References

Baggiolini M . Chemokines and leukocyte traffic. Nature. 1998; 392(6676):565-8. DOI: 10.1038/33340. View

De Marzo A, DeWeese T, Platz E, Meeker A, Nakayama M, Epstein J . Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment. J Cell Biochem. 2004; 91(3):459-77. DOI: 10.1002/jcb.10747. View

Moore B, Arenberg D, Stoy K, Morgan T, Addison C, Morris S . Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am J Pathol. 1999; 154(5):1503-12. PMC: 1866583. DOI: 10.1016/S0002-9440(10)65404-1. View

Russo R, Garcia C, Teixeira M, Amaral F . The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases. Expert Rev Clin Immunol. 2014; 10(5):593-619. DOI: 10.1586/1744666X.2014.894886. View

Li A, Varney M, Singh R . Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin Cancer Res. 2001; 7(10):3298-304. View

Yang H, Cohen P, Rousseau S . IL-1beta-stimulated activation of ERK1/2 and p38alpha MAPK mediates the transcriptional up-regulation of IL-6, IL-8 and GRO-alpha in HeLa cells. Cell Signal. 2007; 20(2):375-80. DOI: 10.1016/j.cellsig.2007.10.025. View

Zhang Y, Wang L, Zhang M, Jin M, Bai C, Wang X . Potential mechanism of interleukin-8 production from lung cancer cells: an involvement of EGF-EGFR-PI3K-Akt-Erk pathway. J Cell Physiol. 2011; 227(1):35-43. DOI: 10.1002/jcp.22722. View

Balkwill F, Burke F . The cytokine network. Immunol Today. 1989; 10(9):299-304. DOI: 10.1016/0167-5699(89)90085-6. View

Zhang G, Gomes-Giacoia E, Dai Y, Lawton A, Miyake M, Furuya H . Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature. Diagn Pathol. 2014; 9:200. PMC: 4245773. DOI: 10.1186/s13000-014-0200-1. View

10.

Chow M, Luster A . Chemokines in cancer. Cancer Immunol Res. 2014; 2(12):1125-31. PMC: 4258879. DOI: 10.1158/2326-6066.CIR-14-0160. View

11.

Lazennec G, Richmond A . Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med. 2010; 16(3):133-44. PMC: 2840699. DOI: 10.1016/j.molmed.2010.01.003. View

12.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

13.

Karin N . Chemokines and cancer: new immune checkpoints for cancer therapy. Curr Opin Immunol. 2018; 51:140-145. DOI: 10.1016/j.coi.2018.03.004. View

14.

Murphy C, McGurk M, Pettigrew J, Santinelli A, Mazzucchelli R, Johnston P . Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer. Clin Cancer Res. 2005; 11(11):4117-27. DOI: 10.1158/1078-0432.CCR-04-1518. View

15.

McGlynn K, Petrick J, London W . Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis. 2015; 19(2):223-38. PMC: 4712629. DOI: 10.1016/j.cld.2015.01.001. View

16.

Bonavia R, Inda M, Vandenberg S, Cheng S, Nagane M, Hadwiger P . EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway. Oncogene. 2011; 31(36):4054-66. PMC: 3537826. DOI: 10.1038/onc.2011.563. View

17.

Balasubramanian A, Munshi N, Koziel M, Hu Z, Liang T, Groopman J . Structural proteins of Hepatitis C virus induce interleukin 8 production and apoptosis in human endothelial cells. J Gen Virol. 2005; 86(Pt 12):3291-3301. DOI: 10.1099/vir.0.81056-0. View

18.

Wang Y, Wang W, Wang L, Wang X, Xia J . Regulatory mechanisms of interleukin-8 production induced by tumour necrosis factor-α in human hepatocellular carcinoma cells. J Cell Mol Med. 2011; 16(3):496-506. PMC: 3822926. DOI: 10.1111/j.1582-4934.2011.01337.x. View

19.

Wilson C, Purcell C, Seaton A, Oladipo O, Maxwell P, OSullivan J . Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis. J Pharmacol Exp Ther. 2008; 327(3):746-59. DOI: 10.1124/jpet.108.143826. View

20.

Hennedige T, Venkatesh S . Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring. Cancer Imaging. 2013; 12:530-47. PMC: 3666429. DOI: 10.1102/1470-7330.2012.0044. View